Immunotherapy approaches to stage IV melanoma

被引：0
|
作者：
Keilholz, U. [1 ]
机构：
[1] Charite Universitatsmedizin, Dept Med 3, Berlin, Germany
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)70287-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：46 / 46
页数：1
相关论文
共 50 条
  • [1] Dendritic cell immunotherapy for stage IV melanoma
    O'Rourke, Michael G. E.
    Johnson, Maree K.
    Lanagan, Catherine M.
    See, Janet L.
    O'Connor, Linda E.
    Slater, Gregory J.
    Thomas, David
    Lopez, Jose Alejandro
    Martinez, Nathan R.
    Ellem, Kay A. O.
    Schmidt, Christopher W.
    MELANOMA RESEARCH, 2007, 17 (05) : 316 - 322
  • [2] Use of immunotherapy and surgery for stage IV melanoma
    Molina, George
    Kasumova, Gyulnara G.
    Qadan, Motaz
    Boland, Genevieve M.
    CANCER, 2020, 126 (11) : 2614 - 2624
  • [3] Disparities in use of immunotherapy for stage III and IV melanoma patients.
    White, Richard L.
    Trufan, Sally Jeanne
    Gower, Nicole Lee
    Neelands, Brittany
    Amin, Asim
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] Management of resected stage III/IV melanoma with adjuvant immunotherapy.
    Johnson, Rebecca
    Atkinson, Victoria
    Bhave, Prachi
    Weppler, Alison Margaret
    Peters, Geoffrey David
    Abed, Afaf
    Lyle, Megan
    Khattak, Muhammad Adnan
    Haydon, Andrew Mark
    Carlino, Matteo S.
    Sandhu, Shahneen Kaur
    Long, Georgina V.
    Menzies, Alexander M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] Stage IV melanoma
    Porensky, Paul
    Chiocca, E. Antonio
    JOURNAL OF NEUROSURGERY, 2012, 117 (02) : 225 - 226
  • [6] Patient with stage IV melanoma with BRAF mutation - immunotherapy or BRAF and MEK inhibitors?
    Cybulska-Stopa, Bozena
    Ziobro, Marek
    ONCOLOGY IN CLINICAL PRACTICE, 2018, 14 (02): : 100 - 103
  • [7] Immunotherapy and survival in stage IV melanoma: A National Cancer Database (NCDB) analysis
    Ahmed, Aabra
    Krishnan, Mridula
    Siu, Margaret
    Walters, Ryan W.
    Silberstein, Peter T.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [8] Surgical Utilization and Outcomes for Patients with Stage IV Melanoma in the Modern Immunotherapy Era
    Lwin, Thinzar M.
    Kaelberer, Zoey
    Ruan, Mengyuan
    Molina, George
    Boland, Genevieve
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (08) : 5005 - 5012
  • [9] Immunotherapy with ipilimumab plus nivolumab in a stage IV melanoma patient during pregnancy
    Menzer, Christian
    Beedgen, Bernd
    Rom, Joachim
    Duffert, Christin M.
    Volckmar, Anna-Lena
    Sedlaczek, Oliver
    Richtig, Erika
    Enk, Alexander
    Jaeger, Dirk
    Hassel, Jessica C.
    EUROPEAN JOURNAL OF CANCER, 2018, 104 : 239 - 242
  • [10] Utilization and impact of immunotherapy in stage IV melanoma using the National Cancer Database
    Conic, R.
    Knackstedt, R.
    Damiani, G.
    Gastman, B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) : S64 - S64
12345